Mind Medicine (MNMD) Misses Q2 EPS by 13c

Mind Medicine (NASDAQ: MNMD) reported Q2 EPS of ($0.50), $0.13 worse than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Mind Medicine (MNMD) click here.

You May Also Be Interested In

• Eli Lilly: Q2 2026 IPR&D charge estimated at $3.02 per share on GAAP and non-GAAP basis
• Vermilion Energy gets TSX approval to repurchase up to 10% of float
• Rambus launches DDR5 9600 server RDIMM chipset for AI workloads